Poolbeg Pharma.
17 announcements.
17 announcements.
| Time | Date | Ticker | Company | Announcement |
|---|---|---|---|---|
| 07:00 | 22-02-2024 | POLB | Poolbeg Pharma | Director/PDMR Shareholding |
| 13:42 | 19-02-2024 | POLB | Poolbeg Pharma | Director Share Purchase |
| 07:00 | 15-02-2024 | POLB | Poolbeg Pharma | Board Role Change and Launch of EIP |
| 07:00 | 17-01-2024 | POLB | Poolbeg Pharma | Further data shows POLB001 potential in cancer CRS |
| 07:00 | 20-12-2023 | POLB | Poolbeg Pharma | RSV AI Drug Candidate Analysis Update |
| 07:00 | 11-12-2023 | POLB | Poolbeg Pharma | POLB 001 Data Presented at ASH |
| 07:00 | 30-11-2023 | POLB | Poolbeg Pharma | Directorate Change |
| 07:05 | 03-11-2023 | POLB | Poolbeg Pharma | POLB001 Data to be Presented at ASH Annual Meeting |
| 07:00 | 01-11-2023 | POLB | Poolbeg Pharma | POLB 001 Oncology Programme Update Meeting |
| 07:00 | 17-10-2023 | POLB | Poolbeg Pharma | Poolbeg Partners with a Nasdaq-Listed Biopharma |
| 07:00 | 29-09-2023 | POLB | Poolbeg Pharma | Favourable Conclusion of Patent Opposition |
| 07:00 | 19-09-2023 | POLB | Poolbeg Pharma | Immunomodulator I Patent Opposition Withdrawal |
| 07:00 | 13-09-2023 | POLB | Poolbeg Pharma | Interim results for the six months to 30 June 2023 |
| 07:00 | 29-06-2023 | POLB | Poolbeg Pharma | AI led programme identifies influenza drug targets |
| 07:00 | 22-06-2023 | POLB | Poolbeg Pharma | Oral Vaccine Programme Moves Forward |
| 07:00 | 24-05-2023 | POLB | Poolbeg Pharma | Board Appointment |
| 14:27 | 11-05-2023 | POLB | Poolbeg Pharma | Results of Annual General Meeting |